D.L. Carlson Investment Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-1,933
Closed -$245K – 155
2021
Q3
$245K Sell
1,933
-431
-18% -$62.7K 0.04% 128
2021
Q2
$393K Sell
2,364
-1,836
-44% -$297K 0.07% 115
2021
Q1
$763K Sell
4,200
-19,610
-82% -$4.55M 0.14% 97
2020
Q4
$4.76M Buy
23,810
+3,005
+14% +$611K 0.86% 44
2020
Q3
$4.56M Buy
20,805
+7,555
+57% +$1.6M 0.97% 38
2020
Q2
$2.53M Buy
13,250
+244
+2% +$42.8K 0.75% 49
2020
Q1
$2.02M Buy
+13,006
New +$1.51M 0.76% 50
2019
Q1
– Sell
-51,383
Closed -$2.55M – 153
2018
Q4
$2.55M Sell
51,383
-6,861
-12% -$420K 0.85% 46
2018
Q3
$5.03M Sell
58,244
-15,822
-21% -$1.13M 1.42% 22
2018
Q2
$4.3M Sell
74,066
-26,129
-26% -$1.28M 1.31% 28
2018
Q1
$4.04M Buy
+100,195
New +$3.78M 1.27% 30

Other funds holding TDOC

D.L. Carlson Investment Group's TDOC Position: Q4 2021 in Review

D.L. Carlson Investment Group sold out of Teladoc Health (TDOC) in Q4 2021, closing a stake of 1,933 shares — an estimated $245K sold.

D.L. Carlson Investment Group first reported a position in TDOC in Q1 2018 and held it in 11 quarters. The position peaked at $5.03M in Q3 2018. 729 funds tracked by Wall St. Rank hold TDOC as of Q4 2021.

  • D.L. Carlson Investment Group reported no remaining Teladoc Health position as of Q4 2021 after selling out during the quarter.
  • D.L. Carlson Investment Group sold 1,933 Teladoc Health shares in Q4 2021, an estimated $245K.
  • D.L. Carlson Investment Group first reported a position in Teladoc Health in Q1 2018 and held it in 11 quarters.
  • D.L. Carlson Investment Group's Teladoc Health position peaked at $5.03M in Q3 2018.
  • 729 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2021.

Based on D.L. Carlson Investment Group's 13F filing for Q4 2021, filed 14 Feb 2022.